BMS-2
BMS-2 is a small molecule inhibitor targeting the tyrosine kinases Met, Flt-3, and VEGFR2. It is utilized in biochemical and cellular research to study oncogenic signaling pathways and has been employed in preclinical in vitro and in vivo models of cancer and angiogenesis.
Product Specifications
CAS Number
888719-03-7
Product Name Alternative
BMS2, BMS-2, BMS 2, c-Met, cMet, cMet/HGFR, HGFR, FLT3, Met, VEGFR2
Field of Research
Cardiovascular Research, Signal Transduction
Purity
98.33% (May vary between batches)
Solubility
DMSO:4.59 mg/mL (10.01 mM)
Smiles
O (C1=C2C (NC=C2) =NC=C1) C3=C (F) C=C (NC (=O) C=4C (=O) N (C=CC4) C5=CC=C (F) C=C5) C=C3
Molecular Formula
C25H16F2N4O3
Molecular Weight
458.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog